Trafalgar International (GCAN) Times Interest Earned (2017 - 2018)
Trafalgar International (GCAN) posted Times Interest Earned of 13.82 for Q3 2018, down 237.39% on a QoQ basis from 10.06 in Q2 2018, and down 126.41% year-over-year from 52.33 in Q3 2017.
Powered by 
Analysis
Trafalgar International (GCAN) Times Interest Earned (2017 - 2018) Analysis & Trends
Trafalgar International has reported Times Interest Earned for 2 years, with the latest figure at 13.82 in Q3 2018.
- On a quarterly basis, Times Interest Earned fell 126.41% year-over-year to 13.82 in Q3 2018; TTM through Sep 2018 was 7.84, a N/A change from a year earlier, with the FY2017 full-year figure at 136.8, up 310.39% from the prior year.
- Times Interest Earned was 13.82 for Q3 2018 at Trafalgar International, down from 10.06 in the prior quarter.
- The five-year high for Times Interest Earned was 52.33 in Q3 2017, with the low at 706.08 in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -21.24 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 114.07 |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -13.82 |
| Jun 30, 2018 | 10.06 |
| Mar 31, 2018 | 46.37 |
| Dec 31, 2017 | 10.82 |
| Sep 30, 2017 | 52.33 |
| Jun 30, 2017 | -30.97 |
| Mar 31, 2017 | -706.08 |